dechloroethylcyclophosphamide has been researched along with Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boddy, AV; Chinnaswamy, G; Cole, M; Errington, J; Foot, A; Veal, GJ | 1 |
| Brennan, C; Hartley, JM; Nicholson, PW; Singer, JM; Souhami, RL | 1 |
| Beijnen, JH; Keizer, HJ; Kerbusch, T; Mathĵt, RA; Ouwerkerk, J; Rodenhuis, S; Schellens, JH | 1 |
2 trial(s) available for dechloroethylcyclophosphamide and Sarcoma
| Article | Year |
|---|---|
The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study.
Topics: Adult; Aged; Antineoplastic Agents; Biotransformation; Cross-Over Studies; Cyclophosphamide; Dexamethasone; Female; Humans; Ifosfamide; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Phosphoramide Mustards; Sarcoma; Sarcoma, Ewing | 1998 |
Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide and metabolites after a 72-h continuous infusion in patients with soft tissue sarcoma.
Topics: Adult; Aged; Algorithms; Antineoplastic Agents, Alkylating; Cyclophosphamide; Female; Humans; Ifosfamide; Infusions, Intravenous; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Sarcoma | 2001 |
1 other study(ies) available for dechloroethylcyclophosphamide and Sarcoma
| Article | Year |
|---|---|
Pharmacokinetics of cyclophosphamide and its metabolites in paediatric patients receiving high-dose myeloablative therapy.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Area Under Curve; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Female; Humans; Male; Mesenchymoma; Phosphoramide Mustards; Rhabdomyosarcoma; Sarcoma; Time Factors; Treatment Outcome | 2011 |